Institution

Ospedale Bellaria

Bologna, ItalyWebsite

Also known as: Ospedale Bellaria "Carlo Alberto Pizzardi"

9running trials
7closed trials
3,839publications (OpenAlex)

Running trials

Recruiting
A Study to Evaluate the Impact of Efgartigimod on Overall Disease Experience of People Suffering From Generalized Myasthenia Gravis (gMG) in Italy
NCT07595653· argenx· Source
Recruiting
Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants With Advanced Parkinson Disease
NCT06965374· AbbVie· Source
Recruiting
Stereotactic Body Radiotherapy (SBRT) for Reirradiation of Inoperable Lung Lesions
NCT07401615· Istituto Clinico Humanitas· Source
Recruiting
Italian PheNotypes Obstructive Sleep Apnea Study
NCT06872242· Istituto Auxologico Italiano· Source
Recruiting
European Study of Prodromal iNPH
NCT05910944· Johan Virhammar· Source
Not yet recruiting
Phase 2, open-label, multicentre, single-arm study to evaluate the activity of the combination of EGFR inhibitors and c-MET inhibitors in patients with platinum-resistant head and neck squamous cell carcinoma after relapse to immunotherapy.
2024-518892-72-00· Phase 2· Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia· Source
Recruiting
A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions
NCT05816382· Phase 2/3· Takeda· Source
Active, not recruiting
A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer
NCT02246621· Phase 3· Eli Lilly and Company· Source
Active, not recruiting
A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer
NCT02107703· Phase 3· Eli Lilly and Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Head and neck cancer1 recruiting
Hydrocephalus1 recruiting
Lung cancer1 recruiting
Myasthenia gravis1 recruiting
Narcolepsy1 recruiting
Obstructive sleep apnoea1 recruiting
Parkinson disease1 recruiting

Closed trials

Completed
Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD)
NCT06182085· Phase 2· PRInnovation GmbH· Source
Terminated
Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations
NCT05267106· Phase 2· Incyte Corporation· Source
Completed
Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens
NCT05217927· Phase 4· Pfizer· Source
Completed
A Study of Soticlestat as an Add-on Therapy in Children, Teenagers, and Adults With Lennox-Gastaut Syndrome
NCT04938427· Phase 3· Takeda· Source
Completed
Regorafenib in Patients With Relapsed Glioblastoma. IOV-GB-1-2020 REGOMA-OSS
NCT04810182· Istituto Oncologico Veneto IRCCS· Source
Completed
Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.
NCT03529045· LivaNova· Source
Completed
Adjuvant Treatment for High-risk Triple Negative Breast Cancer Patients With the Anti-PD-l1 Antibody Avelumab
NCT02926196· Phase 3· Istituto Oncologico Veneto IRCCS· Source

Registry name variants (22)

Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.

Ospedale Bellaria
Bologna, 40139
5 trials
Ospedale Bellaria - Azienda USL di Bologna
Bologna, 40139
4 trials
AUSL Bologna - Ospedale di Bellaria
Bologna
1 trial
- NCT06872242Italian PheNotypes Obstructive Sleep Apnea Study
  Contact: Federica Provini
Bellaria Hospital
Bologna
1 trial
- NCT05910944European Study of Prodromal iNPH
  Contact: Giorgio Palandri, MD, PhD
IRCCS Istituto delle Scienze Neurologiche Bologna, Unità Operativa di Neurologia - Ospedale Bellaria
Bologna, 40139
1 trial
- NCT05217927Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens
Ospedale Bellaria - Azienda Usl Di Bologna /ID# 274463
Bologna, 40139
1 trial
- NCT06965374Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants With Advanced Parkinson Disease
  Contact: Caterina Golotta
Ospedale Bellaria - IRCCS Istituto delle Scienze Neurologiche
Bologna, 40139
1 trial
- NCT06182085Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD)
Ospedale di Bellaria
Bologna, BO
1 trial
- NCT02926196Adjuvant Treatment for High-risk Triple Negative Breast Cancer Patients With the Anti-PD-l1 Antibody Avelumab
Radiotherapy Department, Ospedale Bellaria Carlo Alberto Pizzardi
Bologna, Bologna 40124
1 trial
- NCT07401615Stereotactic Body Radiotherapy (SBRT) for Reirradiation of Inoperable Lung Lesions
  Contact: Elisa D'Angelo, MD, radiation oncologist
AUSL di Bologna - Ospedale Bellaria
Bologna, Emilia-Romagna 40123
Azienda Unita Sanitaria Locale Di Bologna_Ospedale Bellaria - Oncologia Medica
Bologna, Emilia-Romagma 40139
Irccs Institute of Neurological Sciences of Bologna - Bellaria Hospital
Bologna, 40139
IRCCS- Istituto delle Scienze Neurologiche, Bellaria Hospital
Bologna, 40139
IRCCS Ospedale Bellaria
Bologna, 40139
IRCCS-Ospedale Bellaria-Bologna
Bologna, 40139
Ospedale Bellaria - AUSL Bologna
Bologna
Ospedale Bellaria Carlo Alberto Pizzardi - UO Cardiologia e Unità coronarica
Bologna, Emilia-Romagna 40139
Ospedale Bellaria, IRCCS Istituto delle Scienze Neurologiche, AUSL Bologna
Bologna
Ospedale Bellaria, IRCCS Istituto delle Scienze Neurologiche, AUSL di Bologna
Bologna
Ospedale Bellaria-Site Number: 3800009
Bologna, 40139
Ospedale Bellaria, U.O.Cardiologia Az. USL di Bologna
Bologna, 40124
Servizio Sanitario Regionale Emilia-Romagna - Azienda USL di Bologna - Ospedale Bellaria
Bologna

Conditions

Diseases this institution publishes on or runs trials for.

Male hypogonadism (low testosterone)3 works · 0 trials

Institution data: ROR 05fz2yc38 (CC0-1.0)Updated 14 Nov 2026

Report an error